Health Market Update: Advances in hepatitis C treatment: Alert for insurers
Source: Middle East Insurance Review | Oct 2015
New treatments for hepatitis C could lead to a spike in insured costs for this condition and represent a time bomb for insurers, says Mr Colin Weston of RGA.
Archived articles are available to Magazine subscribers only.
For Full Access to
the magazine
SUBSCRIBE here.